Literature DB >> 7728565

Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience.

J N Vauthey1, J M Woodruff, M F Brennan.   

Abstract

BACKGROUND: Prior studies have shown a high rate of local recurrence and a dismal overall prognosis in malignant peripheral nerve sheath tumors (MPNSTs).
METHODS: Thirty-three patients who had undergone primary treatment for localized extremity MPNSTs between 1982 and 1992 were reviewed. These cases were derived from a prospective database of 890 adult extremity soft-tissue sarcomas (STS). MPNSTs were compared with other extremity STS.
RESULTS: MPNSTs were more often high grade and deep compared with other extremity STS (94% vs. 72% [p = 0.009] and 97% vs. 76% [p = 0.01], respectively). Location (upper or lower extremity), size (> 5 cm vs. < or = 5 cm), and status of margins after surgical resection (positive or negative for disease) did not differ between the two groups. When deep and high-grade MPNSTs were compared with deep and high-grade STS, a more aggressive local treatment was applied to MPNSTs with a higher number of amputations for MPNSTs (32%) compared with STS (9%; p < 0.001). In order to obtain adequate margins, 16 of 21 MPNSTs arising from major nerves required either amputation (n = 8) or nerve resection (n = 8). Adjuvant radiotherapy was used in 48% of deep and high-grade MPNSTs, and 3-year local disease-free survival was 70%. Survival of deep and high-grade MPNSTs was comparable with other deep and high-grade STS (3-year survival 50% vs. 69%, respectively; p = 0.1).
CONCLUSION: MPNSTs show adverse clinicopathologic features compared with other STS. However, when treated aggressively, MPNSTs have an outcome similar to other deep and high-grade extremity STS.

Entities:  

Mesh:

Year:  1995        PMID: 7728565     DOI: 10.1007/bf02303627

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

Review 1.  Neurofibromatoses.

Authors:  K L Roos; D W Dunn
Journal:  CA Cancer J Clin       Date:  1992 Jul-Aug       Impact factor: 508.702

2.  Malignant schwannoma. A clinicopathologic study.

Authors:  B C Ghosh; L Ghosh; A G Huvos; J G Fortner
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

Review 3.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

4.  Malignant soft tissue tumors of nerve sheath origin.

Authors:  R N Nambisan; U Rao; R Moore; C P Karakousis
Journal:  J Surg Oncol       Date:  1984-04       Impact factor: 3.454

5.  Localized extremity soft tissue sarcoma: an analysis of factors affecting survival.

Authors:  C Collin; J Godbold; S Hajdu; M Brennan
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

6.  Tumors of the peripheral nervous system.

Authors:  I M Ariel
Journal:  CA Cancer J Clin       Date:  1983 Sep-Oct       Impact factor: 508.702

7.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases.

Authors:  J E Wanebo; J M Malik; S R VandenBerg; H J Wanebo; N Driesen; J A Persing
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

8.  Feasibility of limb salvage and survival in soft tissue sarcomas.

Authors:  C P Karakousis; L J Emrich; U Rao; R M Krishnamsetty
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

9.  Malignant schwannoma--clinical characteristics, survival, and response to therapy.

Authors:  P P Sordillo; L Helson; S I Hajdu; G B Magill; C Kosloff; R B Golbey; E J Beattie
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

10.  The role of multimodality therapy in soft-tissue sarcoma.

Authors:  M F Brennan; E S Casper; L B Harrison; M H Shiu; J Gaynor; S I Hajdu
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

View more
  15 in total

1.  Malignant peripheral nerve sheath tumours of the spine: clinical manifestations, classification, treatment, and prognostic factors.

Authors:  Bin Zhu; Xiaoguang Liu; Zhongjun Liu; Shaomin Yang; Hung-I Liao; Liang Jiang; Feng Wei
Journal:  Eur Spine J       Date:  2011-12-03       Impact factor: 3.134

2.  Malignant Peripheral Nerve Sheath Tumor of the Cervical Spine Treated with Surgical Resection Followed by X-ray Radiotherapy or Carbon Ion Radiotherapy: A Report of Three Cases.

Authors:  Akira Honda; Yoichi Iizuka; Masahiko Okamoto; Shintaro Shiba; Hiromi Koshi; Tokue Mieda; Sho Ishiwata; Yohei Kakuta; Tsuyoshi Tajika; Tatsuya Ohno; Hirotaka Chikuda
Journal:  Spine Surg Relat Res       Date:  2020-02-10

3.  Concurrence of malignant peripheral nerve sheath tumor at the site of complex regional pain syndrome type 1 - a case report -.

Authors:  Yeong Ho Jeong; Eun Joo Choi; Francis Sahngun Nahm
Journal:  Korean J Pain       Date:  2013-04-03

4.  Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.

Authors:  Matthias R Benz; Johannes Czernin; Sarah M Dry; William D Tap; Martin S Allen-Auerbach; David Elashoff; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

5.  Primary paraspinal malignant peripheral nerve sheath tumor.

Authors:  Kyoung-Tae Kim; Yong-Suk Park; Jeong-Taik Kwon; Young-Baeg Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-08-30

Review 6.  Systemic Options for Malignant Peripheral Nerve Sheath Tumors.

Authors:  Ayesha Hassan; Roberto Carmagnani Pestana; Amanda Parkes
Journal:  Curr Treat Options Oncol       Date:  2021-02-27

Review 7.  Factors of influence upon overall survival in the treatment of intracranial MPNSTs. Review of the literature and report of a case.

Authors:  Konstantinos Gousias; Jan Boström; Attila Kovacs; Pitt Niehusmann; Ingo Wagner; Rudolf Kristof
Journal:  Radiat Oncol       Date:  2010-11-24       Impact factor: 3.481

8.  Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients.

Authors:  Elizabeth Shurell; Linh M Tran; Jonathan Nakashima; Kathleen B Smith; Brenna M Tam; Yunfeng Li; Sarah M Dry; Noah Federman; William D Tap; Hong Wu; Fritz C Eilber
Journal:  BMC Cancer       Date:  2014-11-15       Impact factor: 4.430

9.  Malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.

Authors:  Apostolos Pourtsidis; Dimitrios Doganis; Margarita Baka; Despina Bouhoutsou; Maria Varvoutsi; Maria Synodinou; Panagiota Giamarelou; Helen Kosmidis
Journal:  Case Rep Oncol Med       Date:  2014-09-16

10.  Treatment and survival differences across tumor sites in malignant peripheral nerve sheath tumors: a SEER database analysis and review of the literature.

Authors:  Enrico Martin; Ivo S Muskens; J H Coert; Timothy R Smith; Marike L D Broekman
Journal:  Neurooncol Pract       Date:  2018-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.